Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 24;317(4):407-414.
doi: 10.1001/jama.2016.20325.

Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force; Kirsten Bibbins-Domingo  1 , David C Grossman  2 , Susan J Curry  3 , Karina W Davidson  4 , John W Epling Jr  5 , Francisco A R García  6 , Jessica Herzstein  7 , Alex R Kemper  8 , Alex H Krist  9 , Ann E Kurth  10 , C Seth Landefeld  11 , Carol M Mangione  12 , William R Phillips  13 , Maureen G Phipps  14 , Michael P Pignone  15 , Michael Silverstein  16 , Chien-Wen Tseng  17
Affiliations

Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force et al. JAMA. .

Abstract

Importance: Based on data from the 1990s, estimated prevalence of obstructive sleep apnea (OSA) in the United States is 10% for mild OSA and 3.8% to 6.5% for moderate to severe OSA; current prevalence may be higher, given the increasing prevalence of obesity. Severe OSA is associated with increased all-cause mortality, cardiovascular disease and cerebrovascular events, diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes.

Objective: To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for OSA in asymptomatic adults.

Evidence review: The USPSTF reviewed the evidence on the accuracy, benefits, and potential harms of screening for OSA in asymptomatic adults seen in primary care, including those with unrecognized symptoms. The USPSTF also evaluated the evidence on the benefits and harms of treatment of OSA on intermediate and final health outcomes.

Findings: The USPSTF found insufficient evidence on screening for or treatment of OSA in asymptomatic adults or adults with unrecognized symptoms. Therefore, the USPSTF was unable to determine the magnitude of the benefits or harms of screening for OSA or whether there is a net benefit or harm to screening.

Conclusions and recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for OSA in asymptomatic adults. (I statement).

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

LinkOut - more resources